Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection
dc.contributor.author | Shein A.M.S. | |
dc.contributor.author | Wannigama D.L. | |
dc.contributor.author | Hurst C. | |
dc.contributor.author | Monk P.N. | |
dc.contributor.author | Amarasiri M. | |
dc.contributor.author | Badavath V.N. | |
dc.contributor.author | Phattharapornjaroen P. | |
dc.contributor.author | Ditcham W.G.F. | |
dc.contributor.author | Ounjai P. | |
dc.contributor.author | Saethang T. | |
dc.contributor.author | Chantaravisoot N. | |
dc.contributor.author | Thuptimdang W. | |
dc.contributor.author | Luk-in S. | |
dc.contributor.author | Nilgate S. | |
dc.contributor.author | Rirerm U. | |
dc.contributor.author | Tanasatitchai C. | |
dc.contributor.author | Kueakulpattana N. | |
dc.contributor.author | Laowansiri M. | |
dc.contributor.author | Liao T. | |
dc.contributor.author | Kupwiwat R. | |
dc.contributor.author | Rojanathanes R. | |
dc.contributor.author | Ngamwongsatit N. | |
dc.contributor.author | Thammahong A. | |
dc.contributor.author | Ishikawa H. | |
dc.contributor.author | Pletzer D. | |
dc.contributor.author | Leelahavanichkul A. | |
dc.contributor.author | Ragupathi N.K.D. | |
dc.contributor.author | Wapeesittipan P. | |
dc.contributor.author | Ali Hosseini Rad S.M. | |
dc.contributor.author | Kanjanabuch T. | |
dc.contributor.author | Storer R.J. | |
dc.contributor.author | Miyanaga K. | |
dc.contributor.author | Cui L. | |
dc.contributor.author | Hamamoto H. | |
dc.contributor.author | Higgins P.G. | |
dc.contributor.author | Kicic A. | |
dc.contributor.author | Chatsuwan T. | |
dc.contributor.author | Hongsing P. | |
dc.contributor.author | Abe S. | |
dc.contributor.other | Mahidol University | |
dc.date.accessioned | 2023-11-04T18:02:51Z | |
dc.date.available | 2023-11-04T18:02:51Z | |
dc.date.issued | 2023-12-01 | |
dc.description.abstract | Given the rise of multidrug-resistant (MDR) Pseudomonas aeruginosa infections, alternative treatments are needed. Anti-pseudomonal phage therapy shows promise, but its clinical application is limited due to the development of resistance and a lack of biofilm penetration. Recently, adjuvants like CaEDTA have shown the ability to enhance the effectiveness of combined antimicrobial agents. Here, we tested a phage-adjuvant combination and demonstrated the effectiveness of intranasally inhaled phage (KKP10) + CaEDTA in addition to ceftazidime/avibactam (CZA) for chronic P. aeruginosa lung infections. The results emphasize that intranasal inhalation of phage along with CaEDTA can successfully re-sensitize MDR P. aeruginosa to CZA in a triple combination treatment. This promising approach shows potential as a therapy for chronic respiratory tract infections. | |
dc.identifier.citation | Biomedicine and Pharmacotherapy Vol.168 (2023) | |
dc.identifier.doi | 10.1016/j.biopha.2023.115793 | |
dc.identifier.eissn | 19506007 | |
dc.identifier.issn | 07533322 | |
dc.identifier.scopus | 2-s2.0-85175030390 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/90925 | |
dc.rights.holder | SCOPUS | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | |
dc.title | Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection | |
dc.type | Article | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85175030390&origin=inward | |
oaire.citation.title | Biomedicine and Pharmacotherapy | |
oaire.citation.volume | 168 | |
oairecerif.author.affiliation | Yamagata Prefectural Central Hospital | |
oairecerif.author.affiliation | Medizinische Fakultät | |
oairecerif.author.affiliation | Siriraj Hospital | |
oairecerif.author.affiliation | Mae Fah Luang University Hospital | |
oairecerif.author.affiliation | UWA Medical School | |
oairecerif.author.affiliation | Yamagata Prefectural University of Health Sciences | |
oairecerif.author.affiliation | Perth Children's Hospital | |
oairecerif.author.affiliation | Jichi Medical University | |
oairecerif.author.affiliation | The Faculty of Health Sciences | |
oairecerif.author.affiliation | Narsee Monjee Institute of Management Studies, Mumbai | |
oairecerif.author.affiliation | Universitetet i Bergen | |
oairecerif.author.affiliation | Chulalongkorn University | |
oairecerif.author.affiliation | Sahlgrenska Akademin | |
oairecerif.author.affiliation | Yamagata University Faculty of Medicine | |
oairecerif.author.affiliation | Faculty of Medicine, Prince of Songkla University | |
oairecerif.author.affiliation | King Chulalongkorn Memorial Hospital | |
oairecerif.author.affiliation | Kasetsart University | |
oairecerif.author.affiliation | Mae Fah Luang University | |
oairecerif.author.affiliation | University of Otago | |
oairecerif.author.affiliation | Faculty of Medicine Ramathibodi Hospital, Mahidol University | |
oairecerif.author.affiliation | Mahidol University | |
oairecerif.author.affiliation | The Sheffield Medical School | |
oairecerif.author.affiliation | Kitasato University | |
oairecerif.author.affiliation | Charles Darwin University | |
oairecerif.author.affiliation | Faculty of Medicine, Chulalongkorn University | |
oairecerif.author.affiliation | The University of Sheffield | |
oairecerif.author.affiliation | Christian Medical College, Vellore | |
oairecerif.author.affiliation | Telethon Kids Institute | |
oairecerif.author.affiliation | Partner Site Bonn-Cologne |